Steve Cagle is the CEO and a board member of Clearwater, assuming the CEO position in May 2018. Mr. Cagle is responsible for leading Clearwater’s strategic growth plan and managing the company’s overall operations. He has extensive experience leading, innovating, and scaling healthcare and technology businesses, including guiding numerous companies through critical transformation periods. Formerly, Mr. Cagle was president and CEO of Moberg Pharma North America, a subsidiary of Moberg Pharma AB (OMX:MOB), a publicly traded Swedish pharmaceutical company. Prior to its acquisition by Moberg AB, Mr. Cagle was president and CEO of Alterna LLC, a consumer healthcare products company. Mr. Cagle serves as CMP Pharma’s executive chairman, where he has guided its transformation to an institutionally-owned specialty pharmaceutical company.